Influenza Vaccination and Associated Factors among Korean Cancer Survivors : A Cross-Sectional Analysis of the Fourth & Fifth Korea National Health and Nutrition Examination Surveys.
10.3346/jkms.2014.29.8.1061
- Author:
Kyung Hyun CHOI
1
;
Sang Min PARK
;
Kiheon LEE
;
Ju Hyun LEE
;
Joo Sung PARK
Author Information
1. Center for Health Promotion & Cancer Prevention, Dongnam Institute of Radiological & Medical Sciences, Busan, Korea.
- Publication Type:Original Article
- Keywords:
Influenza Vaccines;
Cancer Survivors;
Korean
- MeSH:
Adult;
Age Distribution;
Aged;
Aged, 80 and over;
Comorbidity;
Disease Susceptibility/mortality;
Educational Status;
Female;
Health Behavior;
Humans;
Influenza Vaccines/*therapeutic use;
Influenza, Human/*mortality/*prevention & control;
Male;
Mass Vaccination/*utilization;
Middle Aged;
Neoplasms/*mortality;
Republic of Korea/epidemiology;
Risk Factors;
Sex Distribution;
Social Class;
Survival Rate;
Survivors/*statistics & numerical data
- From:Journal of Korean Medical Science
2014;29(8):1061-1068
- CountryRepublic of Korea
- Language:English
-
Abstract:
Influenza vaccination is important for cancer survivors, a population with impaired immunity. This study was designed to assess influenza vaccination patterns among Korean cancer survivors. In this cross-sectional analysis, data were obtained from standardized questionnaires from 943 cancer survivors and 41,233 non-cancer survivors who participated in the Fourth and Fifth Korea National Health and Nutrition Examination Surveys (2007-2011). We identified the adjusted influenza vaccination rates and assessed factors associated with influenza vaccination using multivariate logistic regression. Cancer survivors tended to have a higher adjusted influenza vaccination rate than the general population. The rates for influenza vaccination in specific cancer types such as stomach, hepatic, colon, and lung cancers were significantly higher than non-cancer survivors. Among all cancer survivors, those with chronic diseases, elderly subjects, and rural dwellers were more likely to receive influenza vaccination; those with cervical cancer were less likely to receive influenza vaccination. Cancer survivors were more likely to receive influenza vaccinations than non-cancer survivors, but this was not true for particular groups, especially younger cancer survivors. Cancer survivors represent a sharply growing population; therefore, immunization against influenza among cancer survivors should be concerned as their significant preventative healthcare services.
